Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 4/20 | 0.55 |
| ▸ | RNPEP | Q9H4A4 | 3/20 | 0.55 |
| ▸ | DNPEP | Q9ULA0 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4324004 | 0.86 | ANPEP (0.55) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL3235398 | 0.82 | ANPEP (0.52) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL800814 | 0.80 | — | — | |
| SCHEMBL14560074 | 0.79 | SMN1; SMN2 (0.55) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL14626876 | 0.79 | ANPEP (0.58) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL9868278 | 0.77 | ANPEP (0.56) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL2824432 | 0.77 | ANPEP (0.55) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL17189454 | 0.76 | ANPEP (0.46) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL21985484 | 0.76 | SMN1; SMN2 (0.37) | ANPEPRNPEPDNPEPSMN1; SMN2RAB9A | |
| SCHEMBL13589522 | 0.75 | CYP2D6 (0.56) | SMN1; SMN2RAB9AGAANPC1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212148-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-07-06 | — | — | US | disclosed |
| CN-110643833-B | Extraction system for separating magnesium from magnesium-containing brine by using secondary amide/tertiary amide composite solvent and extracting lithium, extraction method and application thereof | 湘潭大学 | 2021-04-20 | — | — | CN | disclosed |
| CN-110643833-A | Extraction system for separating magnesium from magnesium-containing brine by using secondary amide/tertiary amide composite solvent and extracting lithium, extraction method and application thereof | 湘潭大学 | 2020-01-03 | — | — | CN | disclosed |
| US-7429574-B2 | 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use | OSI PHARMACEUTICALS, INC. (US) | 2008-09-30 | — | — | US | disclosed |
| US-7160890-B2 | Compounds specific to adenosine A3 receptor and uses thereof | OSI PHARMACEUTICALS, INC. (US) | 2007-01-09 | — | — | US | disclosed |
| US-6680324-B2 | 4-AMINO-6-PHENYL-PYRROLO(2,3-D)PYRIMIDINE DERIVATIVES | OSI PHARMACEUTICALS, INC. | 2004-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212148-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | CPSF6, NFATC1, CPSF1 | ANPEP 3920/4885RNPEP 3130/4885DNPEP 4239/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.